Email this article The experience of using the Brentuximab vedotin in the treatment of children and young adults with primary refractory course and relapses of Hodgkin's lymphoma - PDF (Russian)
Copyright (c) 2020 «D. Rogachev NMRCPHOI»
This work is licensed under a Creative Commons Attribution 4.0 International License.